NCT02898727: A Study of Local Therapy for the Treatment of Brain Metastases From HER2 Positive Breast Cancer

NCT02898727
Breast Cancer Type: HER2+
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Phase 2
Drug Category: Radiation therapy

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: Brain
Additional Notes: 
Exclusions: Patients with leptomeningeal disease
https://ClinicalTrials.gov/show/NCT02898727

Comments are closed.

Up ↑